semaglutide used for type 2 diabetes Ozempic® (semaglutide) GLP-1 RA GLP1 and Semaglutide is Liquid

Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut Microbiota

Katoh N, Kuroda K, Tomikawa J, et al

SGLT2 inhibitors have been shown to reduce major adverse cardiovascular events (MACE, a composite endpoint of myocardial infarction, stroke and cardiovascular death) and hospitalization for heart failure in large clinical trials in patients with type 2 diabetes at high cardiovascular risk

O Neil PM, Birkenfeld AL, McGowan B (2018) Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial

Include leptin-deficient cohorts if mechanistic generalizability is a goal